Human monoclonal antibodies targeting subdominant meningococcal antigens confer cross-protection against gonococcus

Journal:

Science Translational Medicine

Published:

2025-05-21

DOI:

10.1126/scitranslmed.adv0969

Affiliations:

11

Authors:

47

Go to article

Institutions	Authors	Share
GSK Vaccines Institute for Global Health Srl, Italy	26.000000 26.000000 26.000000	0.55
Toscana Life Science Foundation, Italy	10.500000 10.500000	0.22
University of Siena (UNISI), Italy	6.500000	0.14
National Administration of Laboratories and Health Institutes (ANLIS), Argentina	1.000000	0.02
Institute for Biomedical Technologies (ITB), CNR, Italy	1.000000	0.02
University of Turin (UNITO), Italy	0.500000	0.01
Polytechnic University of Milan, Italy	0.500000	0.01
Imperial College London (ICL), United Kingdom (UK)	0.500000	0.01
Siena Biotechnopole Foundation, Italy	0.500000	0.01

Interested in Medical Microbiology?